Efficacy of vedolizumab in patients with inflammatory bowel disease and failure of anti-TNF-antibodies

被引:0
|
作者
Hoog, C. [1 ]
Eberhardson, M. [1 ]
Almer, S. [1 ]
机构
[1] Karolinska Inst, Stockholm, Sweden
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P419
引用
收藏
页码:S310 / S310
页数:1
相关论文
共 50 条
  • [1] ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Dolinger, Michael
    Rolfes, Priya
    Phan, Becky
    Pan, Stephanie
    Dubinsky, Marla
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 : S71 - S72
  • [2] ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Dolinger, Michael
    Rolfes, Priya
    Phan, Becky
    Pan, Stephanie
    Dubinsky, Marla
    [J]. GASTROENTEROLOGY, 2020, 158 (03) : S116 - S116
  • [3] Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease
    Dubinsky, Marla C.
    Cross, Raymond K.
    Sandborn, William J.
    Long, Millie
    Song, Xue
    Shi, Nianwen
    Ding, Yao
    Eichner, Samantha
    Pappalardo, Brandee
    Ganguli, Arijit
    Wang, Anthony
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (09) : 1876 - 1882
  • [4] Efficacy and safety of anti-TNF and vedolizumab in liver transplant recipients with inflammatory bowel disease (IBD)
    Bellanger, C.
    Beaugerie, L.
    Amiot, A.
    du Montcel, S. Tezenas
    Duvoux, C.
    Samuel, D.
    Carbonnel, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S343 - S344
  • [5] Remission state in Inflammatory Bowel Disease patients on anti TNF or vedolizumab: a confocal endomicroscopy study
    Loly, J. P.
    Vieujean, S.
    Reenaers, C.
    Van Kemseke, C.
    Seidel, L.
    Somja, J.
    Louis, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I283 - I283
  • [6] Efficacy and Safety of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease
    Navaneethan, Udayakumar
    Kommaraju, Kiran Kumar
    Edminster, Timothy
    Zhu, Xiang
    Wilson, Kenneth
    Glover, Sarah C.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S812 - S812
  • [7] Clinical experience with vedolizumab in anti-TNF refractory inflammatory bowel patients
    Christopher, B.
    Aoko, O.
    O'Toole, A.
    Patchett, S.
    Smyth, C.
    Sengupta, S.
    Farrell, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S374 - S374
  • [8] The Incidence of Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease Treated with Vedolizumab and Anti-TNF Therapies
    Dubinsky, Marla
    Cross, Raymond, Jr.
    Sandborn, William
    Long, Millie
    Eichner, Samantha
    Wang, Anthony
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S17 - S18
  • [9] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
    Huettemann, Eva
    Muzalyova, Anna
    Groehl, Katharina
    Nagl, Sandra
    Fleischmann, Carola
    Ebigbo, Alanna
    Classen, Johanna
    Wanzl, Julia
    Prinz, Friederike
    Mayr, Patrick
    Schnoy, Elisabeth
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [10] Combining Anti-TNF-α and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series
    Buer, Lydia C. T.
    Hoivik, Marte L.
    Warren, David J.
    Medhus, Asle W.
    Moum, Bjorn A.
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (05) : 997 - 1004